Nacl + Glucose, Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride and glucose, the active ingredients in Nacl + Glucose, Viaflo Baxter, are an electrolyte and carbohydrate solution presented as an injection solution for intravenous use. It provides fluid, electrolyte and energy support in patients who require replacement therapy, such as those with dehydration, electrolyte loss, or low blood sugar. GNH USA supplies Nacl + Glucose, Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nacl + Glucose, Viaflo Baxter is used in clinical situations that require rapid fluid, electrolyte and energy restoration. - Fluid replacement: restores intravascular volume in dehydrated or hypovolemic patients. - Electrolyte replenishment: supplies sodium and chloride to correct electrolyte imbalances. - Hypoglycemia treatment: provides glucose to raise blood sugar in acute low‑glucose episodes. - Adjunct to parenteral nutrition: serves as a carrier for electrolytes and carbohydrate in total parenteral nutrition regimens.

Adverse reactions may occur with any intravenous therapy and should be monitored.

Common Side Effects: - Phlebitis or infusion site pain: irritation at the catheter site. - Hypernatremia: elevated serum sodium if administered excessively. - Hyperglycemia: increased blood glucose levels in susceptible patients. - Mild fever or chills during infusion. - Electrolyte imbalance: transient shifts in serum electrolytes.

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate intervention. - Cardiac arrhythmia: due to rapid electrolyte changes. - Volume overload: leading to pulmonary edema in patients with cardiac failure. - Severe hyperosmolar state: especially in diabetic patients. - Acute renal failure: from abrupt shifts in fluid and electrolytes.

Careful assessment and monitoring are essential when using this intravenous solution. - Assess baseline electrolytes: verify sodium, chloride and glucose levels before infusion. - Monitor blood glucose: check glucose concentrations during and after administration. - Adjust infusion rate in cardiac failure: avoid rapid volume expansion. - Use caution in renal impairment: modify volume and electrolyte content as needed. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Potential drug interactions should be reviewed to prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent hypertonic saline: may cause severe hypernatremia. - High‑dose glucose solutions: increase risk of hyperglycemia. - Loop diuretics: can exacerbate electrolyte depletion. - ACE inhibitors: may potentiate potassium shifts.

Moderate Interactions (Monitor Closely): - Insulin therapy: may require dose adjustment due to glucose load. - Beta‑blockers: can mask hypoglycemia symptoms. - Thiazide diuretics: monitor for combined electrolyte effects. - Corticosteroids: may influence glucose metabolism.